A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects with Obesity or Overweight

Date Added
April 17th, 2025
PRO Number
Pro00142892
Researcher
Robert Malcolm

List of Studies


Keywords
Alcohol, Obesity, Weight Control
Summary

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in the treatment of AUD in subjects with obesity or overweight.

Institution
MUSC
Recruitment Contact
Matthew Woodson
8437924442
woodsonm@musc.edu



-- OR --